Nanotechnology Assisted Drug Delivery Strategies for Chemotherapy: Recent Advances and Future Prospects
Yadav, P.K. Chauhan, D. Yadav, P. Tiwari, A.K. Sultana, N. Gupta, D. Mishra, K. Gayen, J.R. Chourasia, M.K.
Yadav, P.K.
Chauhan, D.
Yadav, P.
Tiwari, A.K.
Sultana, N.
Gupta, D.
Mishra, K.
Gayen, J.R.
Chourasia, M.K.
Publication Date
2025-05-03
End of Embargo
Supervisor
Rights
Peer-Reviewed
Yes
Open Access status
restrictedAccess
Accepted for publication
2025-04-21
Institution
Department
Awarded
Embargo end date
Collections
Additional title
Abstract
In pursuit of the treatment of cancer, nanotechnology engineering has emerged as the simplest and most effective means, with the potential to deliver antitumor chemotherapeutics at the targeted site. Employing nanotechnology for drug delivery provides diverse nanosize particles ranging from one to a thousand nanometers. Reduced size improves drug bioavailability by increasing drug diffusion and decreasing the efflux rate. These nanocarriers offer an enormous scope for modification following the chemical and biological properties of both the drug and its disease. Moreover, these nanoformulations assist in targeting pharmaceutically active drug molecules to the desired site and have gained importance in recent years. Their modern use has revolutionized the antitumor action of many therapeutic agents. Higher drug loading efficiency, thermal stability, easy fabrication, low production cost, and large-scale industrial production draw attention to the application of nanotechnology as a better platform for the delivery of drug molecules. Furthermore, the interaction of nanocarrier technology-assisted agents lowers a drug’s toxicity and therapeutic dosage, reduces drug tolerance, and enhances active drug concentration in neoplasm tissue, thus decreasing the concentration in healthy tissue. Nanotechnology-based medications are being widely explored and have depicted effective cancer management in vivo and in vitro systems, leading to many clinical trials with promising results. This review summarizes the innovative impact and application of different nanocarriers developed in recent years in cancer therapy. Subsequently, it also describes the essential findings and methodologies and their effects on cancer treatment. Compared with conventional therapy, nanomedicines can significantly improve the therapeutic effectiveness of antitumor drugs. Thus, the adverse effects associated with healthy tissues are decreased, and adverse effects are scaled back through enhanced permeability and retention effects. Lastly, future insights assisting nanotechnology in active therapeutics delivery and their scope in cancer chemotherapeutics have also been discussed.
Version
No full-text in the repository
Citation
Yadav PK, Chauhan D, Yadav P, et al (2025) Nanotechnology Assisted Drug Delivery Strategies for Chemotherapy: Recent Advances and Future Prospects. ACS Applied Bio Materials. 8(5): 3601-3622.
Link to publisher’s version
Link to published version
Link to Version of Record
Type
Article